Novolog 100 unit/ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FY8KV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,340
Award facts
- Contract value 100% obligated
- $1,339.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,339.78 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of NovoLog 100 Unit/mL vials (10mL units), a rapid-acting insulin medication commonly used in military and federal healthcare systems. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX. The IDC, valued at $999,999,999.00 and extending through December 2026, serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The place of performance is located in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated consistent capability to meet federal procurement requirements through competitive awards across multiple therapeutic domains. The company serves critical federal customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its extensive portfolio of brand-name and generic medications, specialty pharmaceuticals, and medical supplies. The current delivery order for NovoLog insulin is typical of the company's federal contracting activities with DLA, which range from modest transactions to substantial orders exceeding $45,000, reflecting AmerisourceBergen's versatility in fulfilling diverse federal medical supply needs.
Quick answers
Who was awarded contract SPE2DB25FY8KV?
SPE2DB25FY8KV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FY8KV worth?
The government has obligated $1,340 on SPE2DB25FY8KV.
Is contract SPE2DB25FY8KV an order under another contract?
Yes. SPE2DB25FY8KV is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY8KV competed?
The extent of competition for SPE2DB25FY8KV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award